A microbial supply chain for production of the anti-cancer drug vinblastine
more »
- Technical University of Denmark, Lyngby (Denmark)
- Joint BioEnergy Institute (JBEI), Emeryville, CA (United States); Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- University of Tours (France)
- Max Planck Institute for Chemical Ecology, Jena (Germany)
- Technical University of Denmark, Lyngby (Denmark); Joint BioEnergy Institute (JBEI), Emeryville, CA (United States); Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States); University of California, Berkeley, CA (United States); Chinese Academy of Sciences (CAS), Shenzhen (China). Shenzhen Institute of Advanced Technology
Monoterpene indole alkaloids (MIAs) are a diverse family of complex plant secondary metabolites with many medicinal properties, including the essential anti-cancer therapeutics vinblastine and vincristine. As MIAs are difficult to chemically synthesize, the world’s supply chain for vinblastine relies on low-yielding extraction and purification of the precursors vindoline and catharanthine from the plant Catharanthus roseus, which is then followed by simple in vitro chemical coupling and reduction to form vinblastine at an industrial scale. Here, we demonstrate the de novo microbial biosynthesis of vindoline and catharanthine using a highly engineered yeast, and in vitro chemical coupling to vinblastine. The study showcases a very long biosynthetic pathway refactored into a microbial cell factory, including 30 enzymatic steps beyond the yeast native metabolites geranyl pyrophosphate and tryptophan to catharanthine and vindoline. In total, 56 genetic edits were performed, including expression of 34 heterologous genes from plants, as well as deletions, knock-downs and overexpression of ten yeast genes to improve precursor supplies towards de novo production of catharanthine and vindoline, from which semisynthesis to vinblastine occurs. As the vinblastine pathway is one of the longest MIA biosynthetic pathways, this study positions yeast as a scalable platform to produce more than 3,000 natural MIAs and a virtually infinite number of new-to-nature analogues.
- Research Organization:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- Sponsoring Organization:
- European Union (EU); Novo Nordisk Foundation (NNF); USDOE
- Grant/Contract Number:
- AC02-05CH11231
- OSTI ID:
- 2470808
- Journal Information:
- Nature (London), Journal Name: Nature (London) Journal Issue: 7926 Vol. 609; ISSN 0028-0836
- Publisher:
- Nature Publishing GroupCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Biosynthesis of natural and halogenated plant monoterpene indole alkaloids in yeast
Combination of {gamma}-radiation antagonizes the cytotoxic effects of vincristine and vinblastine on both mitotic arrest and apoptosis
Verazine biosynthesis from simple sugars in engineered Saccharomyces cerevisiae
Journal Article
·
Sun Nov 05 19:00:00 EST 2023
· Nature Chemical Biology
·
OSTI ID:2367187
Combination of {gamma}-radiation antagonizes the cytotoxic effects of vincristine and vinblastine on both mitotic arrest and apoptosis
Journal Article
·
Mon Mar 14 23:00:00 EST 2005
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:20696145
Verazine biosynthesis from simple sugars in engineered Saccharomyces cerevisiae
Journal Article
·
Fri Jul 26 20:00:00 EDT 2024
· Metabolic Engineering
·
OSTI ID:2468688